CZS-241
Product Specifications
UNSPSC Description
CZS-241 is an orally active and selective inhibitor of Polo-like Kinase (PLK) 4 (IC50=2.6 nM). CZS-241 inhibits TRKA with an IC50 value of 2.74 μM. CZS-241 induces apoptosis and arrests cell cycle at S/G2 phase. CZS-241 shows highly potent antiproliferative activity against leukemia cell lines, and exhibits safety against normal cell lines[1].
Target Antigen
Apoptosis; Polo-like Kinase (PLK); Trk Receptor
Type
Reference compound
Related Pathways
Apoptosis;Cell Cycle/DNA Damage;Neuronal Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/czs-241.html
Solubility
10 mM in DMSO
Smiles
FC1=CC=C(C=C1NC(C2=C(C=CC(CNC3=NC4=C(C(NC5=NNC(C)=C5)=N3)C=NN4C(C)C)=C2)Cl)=O)F
Molecular Weight
551.98
References & Citations
[1]Sun Y, et al. Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia. J Med Chem. 2023 Feb 23;66(4):2396-2421.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149912/CZS-241-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149912/
Clinical Information
No Development Reported
CAS Number
3016297-55-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
